In our previous study, NEUROMIDE was found to activate CB1R and improve skin barrier recovery [17], and it has shown effectiveness in an atopic dermatitis model, representative of inflammatory skin disease [18]. The gene discussed is CNR1; the disease is inflammatory skin disease.